InvestorsHub Logo
Followers 826
Posts 119439
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 685

Wednesday, 03/16/2022 8:40:47 PM

Wednesday, March 16, 2022 8:40:47 PM

Post# of 749
FDA approves Rinvoq for second-line ulcerative colitis:

https://finance.yahoo.com/news/rinvoq-upadacitinib-receives-fda-approval-212900389.html

The 45mg dose is approved for (8-week) UC induction therapy, and the 15mg dose is approved for UC maintenance, with 30mg allowed for those with severe disease.

Rinvoq is also FDA-approved for RA and psoriatic arthritis (15mg dose) and for atopic dermatitis (15mg and 30mg), all in the second-line setting.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News